Detalhe da pesquisa
1.
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions.
J Eur Acad Dermatol Venereol
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38738586
2.
Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: Results from a European multi-centre study.
J Eur Acad Dermatol Venereol
; 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38468596
3.
Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances.
J Eur Acad Dermatol Venereol
; 36(10): 1820-1825, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766128
4.
Efficacy and safety of oral nalbuphine extended release in prurigo nodularis: results of a phase 2 randomized controlled trial with an open-label extension phase.
J Eur Acad Dermatol Venereol
; 36(3): 453-461, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34780095
5.
Pruritus Intensity Scales across Europe: a prospective validation study.
J Eur Acad Dermatol Venereol
; 35(5): 1176-1185, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33411947
6.
Google search trends for itch in Europe: a retrospective longitudinal study.
J Eur Acad Dermatol Venereol
; 35(6): 1362-1370, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33295009
7.
Chronic nodular prurigo: clinical profile and burden. A European cross-sectional study.
J Eur Acad Dermatol Venereol
; 34(10): 2373-2383, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32078192
8.
Cross-European validation of the ItchyQoL in pruritic dermatoses.
J Eur Acad Dermatol Venereol
; 33(2): 391-397, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30193410
9.
Position Statement: Linear prurigo is a subtype of chronic prurigo.
J Eur Acad Dermatol Venereol
; 33(2): 263-266, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30288812
10.
Chronic nodular prurigo: Association between comorbidities, itch and quality of life.
J Eur Acad Dermatol Venereol
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38736376
11.
European academy of dermatology and venereology European prurigo project: expert consensus on the definition, classification and terminology of chronic prurigo.
J Eur Acad Dermatol Venereol
; 32(7): 1059-1065, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857299
12.
European EADV network on assessment of severity and burden of Pruritus (PruNet): first meeting on outcome tools.
J Eur Acad Dermatol Venereol
; 30(7): 1144-7, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26370062
13.
Daylight photodynamic therapy: where and when is it possible?
Br J Dermatol
; 176(6): 1440-1441, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28581229
14.
Treatment with 311-nm ultraviolet B enhanced response of psoriatic lesions in ustekinumab-treated patients: a randomized intraindividual trial.
Br J Dermatol
; 166(1): 147-53, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21910714
15.
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry.
Br J Dermatol
; 165(3): 640-5, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21564068
16.
Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D3 analogue in polymorphic light eruption.
Br J Dermatol
; 165(1): 152-63, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21428979
17.
Treatment with 311-nm ultraviolet B accelerates and improves the clearance of psoriatic lesions in patients treated with etanercept.
Br J Dermatol
; 160(1): 186-9, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19067710
18.
Short- to intermediate-term follow-up in patients treated with the combination of 311-nm ultraviolet B phototherapy and biological agents.
Br J Dermatol
; 171(4): 915-7, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24665924
19.
Second-line treatment of limb-threatening diabetic foot infections with intravenous fosfomycin.
J Chemother
; 17(5): 527-35, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16323442
20.
Effects of FR173657, a non-peptide B2 antagonist, on kinin-induced hypotension, visceral and peripheral oedema formation and bronchoconstriction.
Br J Pharmacol
; 120(5): 933-9, 1997 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-9138701